Drug Development Resource Plan
This is a practical guide to building a resource plan for a drug development project — the people and resources needed, when, and how they are allocated, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Resource Plan is
A resource plan is the people and resources needed, when, and how they are allocated. For the full concept and how it works in general, see Resource Planning. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built resource plan gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- Roles and skills needed
- Allocation over time
- Capacity vs demand
- Resource calendar
Drug Development-specific considerations
Tailor the resource plan to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the resource plan would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.